Agena Bioscience
Agena Bioscience
  • 46
  • 45 919
Panel Talk: Standardizing Pharmacogenomics Laboratory Processes and Reporting
Panel Talk: Standardizing Pharmacogenomics Laboratory Processes and Reporting
Sponsored by Agena Bioscience®
Speakers: Kristine Ashcraft, Victoria Pratt, Glenn Sawyer
Precision medicine and pharmacogenomics (PGx) have become increasingly critical components of healthcare, but a lack of standardization in clinical laboratory processes and reporting has, up to this point, hindered widespread adoption and implementation.
In this panel discussion, PGx experts Vicky Pratt, past president of AMP and director of scientific affairs for pharmacogenetics at Agena, and Kristine Ashcraft, founder of YouScript, discuss the current state of PGx standardization and how they see things taking shape for the future by addressing topics including:
- Terminology used to characterize metabolizer status.
- Clinically relevant genes and variants critical for testing.
- Alignment of supporting evidence from key PGx societies.
- Structure and requirements of clinical reports.
Recorded on Tuesday, March 19, 2024
มุมมอง: 227

วีดีโอ

Advocating for DPYD Testing to Advance Patient Safety Based on Insights from Clinical Evidence
มุมมอง 8411 หลายเดือนก่อน
AMP 2023 Workshop recording: From Data to Decisions: Advocating for DPYD Testing to Advance Patient Safety Based on Insights from Clinical Evidence Dr. Vicky Pratt, past president of AMP, and Prof. Dr. Ron van Schaik, past president of ESPT, have been at the forefront of the changing landscape of pharmacogenomic testing. There is increased notoriety and visibility to the importance of DPYD in t...
Rethinking Solid Tumor Profiling: How Complementary Technologies Allow Better Treatment Decisions
มุมมอง 5711 หลายเดือนก่อน
AMP 2023 Workshop recording: Rethinking Solid Tumor Profiling - How Utilizing Complementary Technologies can Allow Laboratories to Guide Better Treatment Decisions Characterizing the genetic profile of lung adenocarcinomas upon initial diagnosis has become a critical step in guiding the management and treatment of patients. The need for detection of multiple biomarkers in a single, limited diag...
Webinar: PGx Testing Developments and Future Directions
มุมมอง 6111 หลายเดือนก่อน
Delve into the latest PGx testing guidelines with our distinguished panelists, past AMP president Dr. Vicky Pratt, and Director of Precision Medicine at LetsGetChecked, Dr. Bronwyn Ramey. Alongside them, Glenn Sawyer, Associate Director for Clinical Genetics at Agena Bioscience, will further enrich the discussion. Together, they'll be shedding light on the current PGx landscape and the promisin...
Webinar: Unlocking Precision Medicine - Implementing a Novel PGx Prescribing Program
มุมมอง 108ปีที่แล้ว
Webinar: Unlocking Precision Medicine - Implementing a Novel Pharmacogenetics (PGx) Prescribing Program Hosted by GenXys Healthcare Systems and Agena Bioscience. During this 45-minute informative webinar, PGx expert Dr. Otito Frances Iwuchukwu and Heather Gerich from Agena Bioscience explore implementing a Pharmacogenomics (PGx) program from start to finish, tackling how to overcome barriers, s...
Webinar: PGx-Guided Pharmacotherapy: Recent Developments & Implementation in Clinical Practice
มุมมอง 146ปีที่แล้ว
Webinar - Pharmacogenetics-Guided Pharmacotherapy: Recent Developments and Implementation in Clinical Practice Clinical pharmacologist, Prof. Stefan Russmann, discussed the latest scientific evidence supporting PGx-guided pharmacotherapy and presented first-hand experience with implementing pharmacogenetics in clinical decision-making. Presenters: Prof. Stefan Russmann, Clinical Pharmacologist ...
Webinar: Performing Population-based Newborn Screening for Cystic Fibrosis in the State of Illinois
มุมมอง 113ปีที่แล้ว
Webinar: Using the Agena Bioscience MassARRAY System to Perform Population-based Newborn Screening for Cystic Fibrosis in the State of Illinois Webinar topics include: - Insights into how early genetic screening can be used to diagnose cystic fibrosis (CF) in newborns. - How CF-related mutations in the CFTR gene can be reliably determined from dried blood spot samples using a high-throughput an...
Webinar: Recent Developments in PGx - Predictive Biomarker Identification and Relevance
มุมมอง 127ปีที่แล้ว
Presented by: Dr. David Kisor, Manchester University Newly identified biomarkers, and evidence to support their potential pharmacogenomic (PGx) relevance, can help address challenges involved with optimizing personalized drug therapy. In this webinar, Dr. David Kisor from Manchester University presents the latest evidence supporting newly identified (predictive) biomarkers for pharmacogenomics ...
Advancement of Pharmacogenomic (PGx) Testing: Development of Evidence-based Guidelines
มุมมอง 1592 ปีที่แล้ว
AMP 2022 corporate workshop presented by Agena Bioscience: Advancement of Pharmacogenomic (PGx) Testing - Development of Evidence-based Guidelines and the Ongoing Effort to Drive Alignment with Regulatory Bodies Dr. Kelly E. Caudle discusses considerations behind CPIC guideline development and ongoing work to continually evolve the list of drug-gene interactions recognized by the FDA. Learn abo...
Webinar: Authenticating Laboratory Results - Molecular Sample Tracking for NGS Laboratories
มุมมอง 1623 ปีที่แล้ว
Effective sample identification and tracking can minimize risks of sample mix-up and authenticate laboratory results. Labs implement rigorous quality systems to ensure chain of custody for specimens. A specimen is often subject to different molecular biology workflows, including next generation sequencing (NGS) which can be complex as it involves transfer of specimens between multiple steps inc...
Webinar: Detection of therapeutically targetable mutations in NSCLC
มุมมอง 1773 ปีที่แล้ว
Webinar: Detection of therapeutically targetable mutations in NSCLC: Is there a one size fits all cell free DNA test? Summary: Detecting tumor-specific mutations using circulating cell free DNA analysis has diagnostic and therapeutic applications. Leading experts, Prof. Ed Schuuring and Dr. Darryl Irwin, will discuss the clinical applications of circulating cell free DNA (ccfDNA) in non-small c...
Webinar: The Promise of Liquid Biopsy for Individualizing Cancer Care
มุมมอง 2.4K3 ปีที่แล้ว
Klaus Pantel, Chairman of the Institute of Tumor Biology at University Medical Center Hamburg-Eppendorf, reviews how liquid biopsy analyses can provide information for the early detection of cancer and identify cancer patients at risk of relapse. The approach may also serve to monitor tumor evolution, therapeutic targets, or mechanisms of resistance on metastatic cells. Liquid biopsies show par...
Detection & Discrimination of SARS-CoV-2 Variants of Concern - An Alternative Approach to NGS
มุมมอง 2373 ปีที่แล้ว
From this 2021 APHL Conference Innovate! Session, you can learn how to rapidly and cost-effectively test for key SARS-CoV-2 variants of concern. This educational workshop provides an overview of a novel approach for the detection of 32 unique mutations and differentiation of 12 SARS-CoV-2 variants of concern utilizing a straightforward workflow with simplified results interpretation. Utilize th...
Webinar: Responding to Emerging SARS CoV 2 Variants
มุมมอง 1443 ปีที่แล้ว
Webinar: Responding to Emerging SARS-CoV-2 Variants - The Impact on Existing Diagnostic Testing and the Clinical Utility of Differentiation Assays As new variants of SARS-CoV-2 circulate around the globe, there is growing concern among clinical laboratories that these variants may impact their ability to accurately detect the virus. Understanding the impact of these variants on molecular testin...
Hybrid Alleles: Why It's Important to Detect Them & How Agena Does it Better
มุมมอง 3003 ปีที่แล้ว
Most PGx copy number detection methods cannot detect hybrid alleles. They only look at one or two regions on the gene. That is not enough. You need a technology that looks broadly across the gene to catch these structural changes. The VeriDose® CYP2D6 Panel accurately detects CNVs even in the presence of difficult to detect hybrid alleles. It interrogates 22 points in 7 regions of the CYP2D6 ge...
Webinar: Responding to the COVID-19 Pandemic - Clinical Laboratories Perspectives
มุมมอง 1134 ปีที่แล้ว
Webinar: Responding to the COVID-19 Pandemic - Clinical Laboratories Perspectives
Webinar: A Pharmacogenetic (PGx) Blindspot: The Prevalence and Impact of CYP2D6 Hybrid Alleles
มุมมอง 7814 ปีที่แล้ว
Webinar: A Pharmacogenetic (PGx) Blindspot: The Prevalence and Impact of CYP2D6 Hybrid Alleles
Webinar: Going beyond EGFR: Evaluating technologies for molecular genetic testing in NSCLC
มุมมอง 1884 ปีที่แล้ว
Webinar: Going beyond EGFR: Evaluating technologies for molecular genetic testing in NSCLC
Webinar: Evaluating Drug-Drug Interactions: Implications of Phenoconversions
มุมมอง 1544 ปีที่แล้ว
Webinar: Evaluating Drug-Drug Interactions: Implications of Phenoconversions
MassARRAY® System by Agena Bioscience - 2020
มุมมอง 3.3K4 ปีที่แล้ว
MassARRAY® System by Agena Bioscience - 2020
Webinar: Targeted Detection of MET and NTRK Oncogenic Variants in Routine Molecular Analysis
มุมมอง 2105 ปีที่แล้ว
Webinar: Targeted Detection of MET and NTRK Oncogenic Variants in Routine Molecular Analysis
AMP 2019 PGx Workshop: The Prevalence and Impact of CYP2D6 Hybrid Alleles
มุมมอง 2755 ปีที่แล้ว
AMP 2019 PGx Workshop: The Prevalence and Impact of CYP2D6 Hybrid Alleles
Low Cost, High Sensitivity: The Advantages of MALDI-TOF for Liquid Biopsy and Solid Tumor Profiling
มุมมอง 1655 ปีที่แล้ว
Low Cost, High Sensitivity: The Advantages of MALDI-TOF for Liquid Biopsy and Solid Tumor Profiling
Webinar: PGx Beyond Drug-Metabolizing Enzymes - A Multigene Approach to Predicting Drug Response
มุมมอง 2045 ปีที่แล้ว
Webinar: PGx Beyond Drug-Metabolizing Enzymes - A Multigene Approach to Predicting Drug Response
Chinese Webinar: Application of DNA Methylation in Early Cancer Screening and Diagnosis
มุมมอง 1.4K5 ปีที่แล้ว
Chinese Webinar: Application of DNA Methylation in Early Cancer Screening and Diagnosis
Webinar: Hereditary Cancer Risk Assessment - Benefit vs. Cost in Precision Medicine
มุมมอง 605 ปีที่แล้ว
Webinar: Hereditary Cancer Risk Assessment - Benefit vs. Cost in Precision Medicine
Chinese Webinar: Clinical Applicability of Multi-site PGx Detection for Cardiovascular Diseases
มุมมอง 675 ปีที่แล้ว
Chinese Webinar: Clinical Applicability of Multi-site PGx Detection for Cardiovascular Diseases
Webinar: PGx Characterization of Challenging Samples: Management of Low-Quality DNA & Hybrid Alleles
มุมมอง 1025 ปีที่แล้ว
Webinar: PGx Characterization of Challenging Samples: Management of Low-Quality DNA & Hybrid Alleles
Chinese Webinar: PGx Solutions for Precision Medicine used for Psychiatric Diseases
มุมมอง 595 ปีที่แล้ว
Chinese Webinar: PGx Solutions for Precision Medicine used for Psychiatric Diseases
Webinar: Detection of Medulloblastoma-Associated DNA Methylation Patterns
มุมมอง 3145 ปีที่แล้ว
Webinar: Detection of Medulloblastoma-Associated DNA Methylation Patterns

ความคิดเห็น

  • @PappuPappu-kf8ww
    @PappuPappu-kf8ww ปีที่แล้ว

    th-cam.com/video/65D7HZ9LN9s/w-d-xo.html